Results 71 to 80 of about 86,819 (232)

Biologic Therapy in COVID-19. [PDF]

Arch Bronconeumol, 2021
González-Gay MA, Castañeda S, Ancochea J.   +2 more
europepmc   +1 more source

Medical audit guideline about rheumatoid arthritis diagnosis and treatment

Revista de la Facultad de Ciencias Médicas de Córdoba, 2019
Introduction: rheumatoid arthritis is a frequent inflammatory disease and a leading cause of potentially-treatable disability. Rheumatoid arthritis is associated with an increased risk of general morbidity and mortality.
Alejandra Babini, Gisela Aguilera, Susana Bonardo, María Eugenia Farfan, Verónica Moreno   +4 more
doaj   +1 more source

Aberrant signaling pathways in medulloblastomas: a stem cell connection

Arquivos de Neuro-Psiquiatria, 2010
Medulloblastoma is a highly malignant primary tumor of the central nervous system. It represents the most frequent type of solid tumor and the leading cause of death related to cancer in early childhood.
Carolina Oliveira Rodini, Daniela Emi Suzuki, Adriana Miti Nakahata, Márcia Cristina Leite Pereira, Luciana Janjoppi, Silvia Regina Caminada Toledo, Oswaldo Keith Okamoto   +6 more
doaj   +1 more source

Uso de terapia biológica con tejido adiposo microfragmentado intraarticular en pacientes con patología de rodilla Noviembre 2021/2022

, 2022
J. Hernandez, Franco Cordivani Maloni, Eduardo Bustillo   +2 more
openalex   +1 more source

Terapia biológica no tratamento da psoríase moderada a grave: revisão sistemática / Biological therapy in the treatment of moderate to severe psoriasis: systematic review [PDF]

, 2021
Camilla Feitosa Jacquiminut, Geovana Martins Azevedo, Liana de Lima Amazonas   +2 more
openalex   +1 more source

Costos versus beneficios de la terapia biológica y perfil de utilización actual

Revista Cubana de Medicina Militar
Introducción: La terapia biológica es una de las últimas novedades farmacológicas en los esquemas terapéuticos de varias afecciones. Sus beneficios son indiscutibles; sin embargo, los costos, eventos adversos y los perfiles de utilización merecen un ...
Eduardo Xavier Macias Collahuazo, Henry David Vásconez Vásconez, Maryuri Alexandra Zamora Cusme, Víctor Hugo Vásconez Samaniego   +3 more
doaj  

Baixa prevalência de PPD reativo prévia ao uso de infliximabe: estudo comparativo em população amostral do Hospital Geral de Fortaleza Low prevalence of reactive PPD prior to infliximab use: comparative study on a population sample of Hospital Geral de Fortaleza

Revista Brasileira de Reumatologia, 2011
OBJETIVO: Identificar infecção tuberculosa em pacientes reumatológicos em uso de infliximabe, através do PPD realizado como pré-requisito ao início da terapia.
Maria Roseli Monteiro Callado, José Rubens Costa Lima, Christiane Aguiar Nobre, Walber Pinto Vieira   +3 more
doaj   +1 more source

[Biological therapy as an alternative treatment for cytokine release syndrome in patients with COVID-19]. [PDF]

Rev Colomb Reumatol, 2022
Solis Cartas U.
europepmc   +1 more source

23rd Congress of the European Hematology Association Stockholm, Sweden, June 14‐17, 2018

, 2018
HemaSphere, Volume 2, Issue S1, Page 1-1113, June 2018.
wiley   +1 more source

Particularităţi în terapia biologică cu Infliximab la pacienţii cu rectocolită ulcerohemoragică

Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, 2019
Rectocolita ulcerohemoragică (RCUH) este o afecțiune digestivă cronică, caracterizată de inflamarea pereților colonului, cu afectarea inițială a rectului și implicarea în mod continuu a întregului intestin gros, cu multiple complicații.
Svetlana Chişlaru, Ion Ţîbîrnă, Rodica Bugai, Doina Munteanu, Elena Platon, Elena Josan   +5 more
doaj